As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...
The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...
Dr Pandey shares key insights on dosing, monitoring, and patient education to sustain therapy and improve outcomes. Essential for cardiologists and PCPs!
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS candidate RFK Jr told senators the GLP-1s are ‘miracle drugs’ but shouldn’t ...
CVS Health Corp. $66.56 3.34 5.28% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback